Avtozma, which is Celltrion’s twelfth biosimilar to be approved by the EC, is a recombinant humanised monoclonal antibody ...

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European ...

South Korean firm Celltrion announced that the European Commission (EC) has granted marketing authorization for Avtozma ...

South Korean pharmaceutical firm Celltrion announced Monday that Avtozma, a biosimilar of Actemra, has received approval from the European Commission. The approval covers major indications of the ...

With medicinal mushrooms leading the trend in mental health, Sunset City Mushrooms in Calgary has set forth to bring new and intuitive mushroom based products to market CALGARY, AB / ACCESS Newswire / ...

Celltrion, a major Korean biopharmaceutical firm, said Monday its new biosimilar for an autoimmune disease treatment has ...

Celltrion announced on the 24th that it has received product approval from the European Commission (EC) for ACTEMRA ...

LG Display, the world's leading innovator of display technologies, announced today that it has officially begun mass production of the industry's first 40-inch Pillar to Pillar (P2P) automotive ...

Avtozma is the 12th biosimilar from Celltrion to receive approval from the EC. Credit: © CELLTRION INC. All Rights Reserved.

Celltrion today announced that the European Commission (EC) has granted marketing authorization for Avtozma® (CT-P47), a ...

JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA ® (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and ...

Biosimilar insulin glargine access in Europe correlates with significant price reductions of originator products, enhancing affordability and accessibility. The study observed a 21.6% average ...